Gemmus Pharma
Gemmus develops innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$13—20m (Dealroom.co estimates May 2014.)
San Francisco California (HQ)
Authorizing premium user...